1475-6366

Journal of Enzyme Inhibition and Medicinal Chemistry

Informa UK (Taylor & Francis)

View prefix report (10.1080)

Health Score

0 Fair

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 3264 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact3264 DOIs
2

Attach ORCID iDs across 2513 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact2513 DOIs
3

Add license metadata to 1763 records

License metadata tells indexers and readers how each article may be reused.

High impact1763 DOIs

DOIs for this ISSN

Showing the top 5 of 3264 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Biological Evaluation of Several Coumarin Derivatives Design… (10.1080/1475636031000069291)
Abstract References ORCID License
247.71 299
2 The role of fluorine in medicinal chemistry (10.1080/14756360701425014)
Abstract ORCID License
215.02 735
3 Tyrosinase Inhibition: General and Applied Aspects (10.1080/14756360210000010923)
Abstract References ORCID License
213.35 135
4 Review Article (10.1080/14756360410001689540)
Abstract ORCID License
208.20 596
5 Structure-based drug discovery of carbonic anhydrase inhibit… (10.3109/14756366.2012.672983)
Abstract ORCID License
208.20 596
6 Unsymmetrical 1,1′-disubstituted Ferrocenes: Synthesis of Co… (10.1080/1475636021000006261)
Abstract References ORCID License
206.82 116
7 Pharmacological significance of triazole scaffold (10.3109/14756360903524304)
Abstract ORCID License
204.44 531
8 An overview of the alpha-, beta- and gamma-carbonic anhydras… (10.3109/14756366.2014.910202)
Abstract ORCID License
194.16 387
9 EFFECT OF RHUS CORIARIA L. (ANACARDIACEAE) ON SUPEROXIDE RAD… (10.1080/1475636031000069273)
Abstract References ORCID License
186.92 73
10 Ciprofloxacin: review on developments in synthetic, analytic… (10.3109/14756360903373350)
Abstract ORCID License
185.02 292
11 Carbonic anhydrases: from biomedical applications of the inh… (10.3109/14756366.2013.761876)
Abstract ORCID License
184.57 288
12 Antibacterial Co(II), Cu(II), Ni(II) and Zn(II) Complexes of… (10.1080/14756360290024218)
Abstract References ORCID License
183.88 68
13 Sulfa and trimethoprim-like drugs – antimetabolites acting a… (10.3109/14756366.2013.787422)
Abstract ORCID License
183.65 280
14 Natural, semisynthetic and synthetic tyrosinase inhibitors (10.3109/14756366.2015.1004058)
Abstract ORCID License
178.79 241
15 Structural annotation of human carbonic anhydrases (10.3109/14756366.2012.737323)
Abstract ORCID License
178.24 237
16 Medicinal significance of benzothiazole scaffold: an insight… (10.3109/14756366.2012.720572)
Abstract ORCID License
178.11 236
17 Synthesis of 4-benzyl-1,3-thiazole derivatives as potential… (10.1080/14756360802519558)
Abstract ORCID License
176.70 226
18 Isatin-derived Antibacterial and Antifungal Compounds and th… (10.1080/14756360410001710383)
Abstract ORCID License
175.83 220
19 Inhibition of Jack Bean Urease by 1,4-benzoquinone and 2,5-d… (10.1080/1475636021000011670)
Abstract References ORCID License
174.04 54
20 Chalcones isolated from<i>Angelica keiskei</i>inhibit cystei… (10.3109/14756366.2014.1003215)
Abstract ORCID License
173.70 206
21 <i>In vitro</i>antioxidant activity of silymarin (10.1080/14756360802188081)
Abstract ORCID License
172.08 196
22 Phenolic phytochemical displaying SARS-CoV papain-like prote… (10.3109/14756366.2012.753591)
Abstract ORCID License
170.91 189
23 A series of cinnamic acid derivatives and their inhibitory a… (10.1080/14756360902779326)
Abstract ORCID License
170.39 186
24 Non-peptidic Chemokine Receptors Antagonists as Emerging Ant… (10.1080/14756360290024227)
Abstract References ORCID License
167.21 46
25 Taking advantage of tumor cell adaptations to hypoxia for de… (10.1080/14756360902784425)
Abstract ORCID License
166.90 167
26 Metal binding and antibacterial activity of ciprofloxacin co… (10.1080/14756360310001624948)
Abstract ORCID License
165.91 162
27 Oleanolic acid and related derivatives as medicinally import… (10.1080/14756360701633187)
Abstract ORCID License
165.91 162
28 Metalloantibiotics: Synthesis and Antibacterial Activity of… (10.1080/14756360310001624939)
Abstract ORCID License
165.31 159
29 Synthesis of diaryl ethers with acetylcholinesterase, butyry… (10.1080/14756366.2016.1189422)
Abstract ORCID License
165.31 159
30 A new approach to antiglaucoma drugs: carbonic anhydrase inh… (10.3109/14756366.2011.597749)
Abstract ORCID License
164.90 157
31 Zinc Complexes of Benzothiazole-derived Schiff Bases with An… (10.1080/1475636031000071817)
Abstract ORCID License
164.69 156
32 Antioxidant, antiradical, and anticholinergic properties of… (10.3109/14756366.2015.1018244)
Abstract ORCID License
163.42 150
33 Biomimetic CO <sub>2</sub>… (10.3109/14756366.2012.761608)
Abstract ORCID License
162.55 146
34 Acidic Nonsteroidal Anti-inflammatory Drugs Inhibit Rat Brai… (10.1080/1475636021000049726)
Abstract References ORCID License
162.32 41
35 Transition Metal Acetylsalicylates and Their Anti-inflammato… (10.1080/14756360290030734)
Abstract References ORCID License
162.32 41
36 Measurement of antioxidant ability of melatonin and serotoni… (10.1080/14756360701626223)
Abstract ORCID License
162.10 144
37 Heavy Metal Ions Inhibition of Jack Bean Urease: Potential f… (10.1080/14756360310001650237)
Abstract ORCID License
161.42 141
38 Biochemical properties of a novel and highly thermostable ba… (10.3109/14756366.2012.703185)
Abstract ORCID License
161.42 141
39 Antibacterial, antifungal and cytotoxic properties of novel… (10.1080/14756360600810340)
Abstract ORCID License
160.96 139
40 Synthesis of 4,5-disubstituted-2-thioxo-1,2,3,4-tetrahydropy… (10.1080/14756366.2016.1198901)
Abstract ORCID License
160.96 139
41 Dithiocarbamates strongly inhibit the β-class carbonic anhyd… (10.3109/14756366.2011.641015)
Abstract ORCID License
160.25 136
42 <i>In-vitro</i> antibacterial, antifunga… (10.1080/14756360500043257)
Abstract ORCID License
159.53 133
43 (3,4-Dihydroxyphenyl)(2,3,4-trihydroxyphenyl)methanone and i… (10.3109/14756366.2012.670807)
Abstract ORCID License
159.04 131
44 Mini Review (10.1080/14756360410001704443)
Abstract ORCID License
158.04 127
45 Carbonic anhydrase and acetylcholinesterase inhibitory effec… (10.3109/14756366.2014.928704)
Abstract ORCID License
158.04 127
46 Carbonic anhydrase inhibitors: guaiacol and catechol derivat… (10.3109/14756366.2014.956310)
Abstract ORCID License
158.04 127
47 In-vitro antibacterial, antifungal and cytotoxic activities… (10.1080/14756360500141911)
Abstract ORCID License
157.53 125
48 Acetylcholinesterases – the structural similarities and diff… (10.1080/14756360701421294)
Abstract ORCID License
157.27 124
49 Carbonic anhydrase inhibitory properties of novel sulfonamid… (10.3109/14756366.2012.750311)
Abstract ORCID License
157.27 124
50 Inhibition of dipeptidyl peptidase IV (DPP IV) is one of the… (10.1080/14756360802610761)
Abstract ORCID License
157.01 123